Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHSE: 688488)
Health Care · Biotechnology · CN
CN¥15.75
-5.29% today · +7.1% 1Y
Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHSE: 688488) operates in the Biotechnology industry within the Health Care sector. The company is valued at $989.43M and employs 760 people.
Over the last twelve months the share price has gained 7.1%, trading between 11.40 and 22.55.
Tweenvest scores Jiangsu Aidea Pharmaceutical Group Co., Ltd. across four factors: quality 57/100, value 62/100, growth 88/100. Its strongest factor is growth.
688488 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $989.43M
- Revenue (TTM)
- $106.37M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.48
- 52-week high
- CN¥22.55
- 52-week low
- CN¥11.40
- Avg volume (3M)
- —
- Shares outstanding
- 420.78M
- Employees
- 760
- Next earnings
- —
About Jiangsu Aidea Pharmaceutical Group Co., Ltd.
Jiangsu Aidea Pharmaceutical Co., Ltd. specializes in the research, manufacturing, and commercialization of diverse pharmaceutical products. Its extensive offerings encompass a range of medications including folium sennae granules, powdered bacillus tablets, clindamycin hydrochloride capsules, sodium bicarbonate tablets, nitrendipine tablets, metronidazole tablets, compound gentamycin sulfate and procaine hydrochloride sulfate granules, and cefradine capsules. The company also provides pharmaceutical raw materials. Established in 2009, Jiangsu Aidea Pharmaceutical is headquartered in Yangzhou, China.
- ISIN
- CNE1000041S6
- Founded
- 2009
- Listed since
- Jul 20, 2020
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Aktis Oncology, Inc.NasdaqGS: AKTS | $1.01B | $17.35 | -4.41% |
| Adlai Nortye Group Ltd.NasdaqGM: ANL | $1.01B | $14.30 | -8.45% |
| Cullinan Therapeutics, Inc.NasdaqGS: CGEM | $999.43M | $15.23 | -1.93% |
| Philogen S.p.A.BIT: PHIL | $991.45M | €21.70 | -1.36% |
| Basilea Pharmaceutica AGSWX: BSLN | $979.21M | CHF65.70 | +0.31% |
| Shanghai Haohai Biological Technology Co., Ltd.SEHK: 6826 | $943.26M | HK$16.11 | +0.25% |
| Kura Oncology, Inc.NasdaqGS: KURA | $942.98M | $10.36 | -2.26% |
| Ascletis Pharma Inc.SEHK: 1672 | $936.85M | HK$6.96 | -14.23% |
Figures last refreshed Oct 11, 2026.